Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yinqiao Xiashi Formula is a Traditional Chinese Medicine (TCM) herbal preparation developed by researchers at Beijing Ditan Hospital, Capital Medical University. It is specifically designed for the treatment of viral infections of the central nervous system, including viral encephalitis and viral meningitis. In clinical trial settings, it is often evaluated as part of a combined regimen with Xuanling Yinhuang Formula and Angong Niuhuang Bolus. The formula is based on TCM principles of clearing heat, detoxifying, and resolving dampness to alleviate symptoms and improve clinical outcomes in patients with acute viral brain infections. It aims to provide evidence-based medical support for the use of TCM in the prevention and control of encephalitis and meningitis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yinqiao Xiashi Formula.